This document is a publication of a patent application filed with the USPTO, specifically application number US20260083706A1, titled 'Methods for treating epilepsy using 5HT receptor agonists'. The application, filed on May 29, 2025, by inventor Scott C. Baraban, describes methods for treating epilepsy disorders utilizing a 5HT receptor agonist or a pharmaceutically acceptable salt thereof. The CPC classifications indicate relevance to pharmaceutical compositions and therapeutic uses.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property and market exclusivity for novel treatments in the epilepsy space. Companies involved in pharmaceutical research and development, particularly those focusing on neurological disorders or serotonin receptor modulation, should be aware of this filing for competitive intelligence and potential licensing opportunities.